La sociedad editorial
Quiénes somos, cómo funciona el modelo de propiedad de los miembros y a dónde va el dinero.
ScienceBank Publishing Society es una sociedad de publicación académica dirigida por sus miembros. Existimos para hacer que la revisión por pares rigurosa y la publicación en acceso abierto sean asequibles para investigadores de todo el mundo, financiadas por las membresías en lugar de cobrar a los autores por publicar.
La publicación académica se ha alejado de los investigadores a quienes sirve. Los cargos por procesamiento de artículos ponen el acceso abierto fuera del alcance de muchos autores, y el valor creado por la revisión por pares rara vez revierte en las personas que la realizan. ScienceBank se basa en un modelo diferente: una sociedad editorial que sus miembros poseen y financian.
Los miembros financian la Sociedad mediante una membresía anual. A cambio, los miembros publican sin cargos por procesamiento de artículos, y los revisores y editores reciben una compensación por su trabajo. Los no miembros también pueden publicar en cualquier comunidad mediante una tarifa fija y transparente. Dado que la Sociedad está financiada por sus miembros, nuestros incentivos están alineados con los investigadores, no con la maximización del volumen de artículos.
Cada comunidad en ScienceBank elige el modelo de revisión por pares que se adapta a su campo: simple ciego, doble ciego, abierto o revisión pospublicación. Las revisiones están basadas en anotaciones y son de carácter constructivo, y los revisores reciben una remuneración por las revisiones completadas.
ScienceBank está guiada por un Consejo Editorial compuesto por investigadores en activo. Puede consultar el Consejo actual en la página del Consejo Editorial.
Publicamos un informe anual de transparencia que abarca nuestras finanzas, estadísticas de publicación y membresía. Consulte el informe de transparencia.
23
comunidades de investigación activas
40
artículos de acceso abierto publicados
Editor-in-Chief, Clinical Ophthalmology · 2026–present
Instituto de Microcirugía Ocular
Lucía González-Buendía, is an ophthalmologist specializing in medical retina, combining clinical practice with academic and scientific work in ophthalmology
Editor-in-Chief, Global Neuroscience and Brain Health · 2026–present
International Islamic University Malaysia
MBBCH, MSc, MD, PhD, FAAS, CLP
Editor-in-Chief, Nuclear Science and Technology · 2026–present
Universidad Nacional de Colombia
Dr. David Galeano is a engineer, energy systems specialist with more than 18 years of experience in the electric power sector, innovation strategy, and regulatory analysis. He currently serves as Chief Editor of the Nuclear Science and Technology community at ScienceBank, bringing a multidisciplinary perspective that integrates nuclear engineering, data science, public policy, and energy economics to support rigorous scientific dissemination and evidence-based decision-making. Dr. Galeano holds a Ph.D. in Physics from the University of Antioquia, an M.Sc. in Statistics from the National University of Colombia, and a degree in Electrical Engineering, complemented by postgraduate training in project evaluation, machine learning, and nuclear security. His doctoral research focused on advanced quantum systems and topological properties of materials, while his professional work has centered on energy systems modeling, risk analysis, and strategic planning for complex infrastructure. He has completed specialized nuclear training at the International Atomic Energy Agency (IAEA) and Instituto Balseiro in Argentina and is a Certified Nuclear Security Specialised Professional (CNSsP) from the World Institute for Nuclear Security (WINS). His technical interests span nuclear energy deployment, small modular reactors, radiation science, fuel cycles, and the integration of nuclear power into sustainable energy systems, particularly in emerging economies. Professionally, Dr. Galeano works at EPM, one of Latin America’s largest public utilities, where he has held roles in innovation, energy regulation, market analysis, and strategic business development. His work includes feasibility studies for advanced energy technologies, regulatory impact modeling, demand forecasting, and financial projections for large-scale energy investments. In academia, he teaches nuclear energy courses at the National University of Colombia and the University of Antioquia and coordinates postgraduate-level training programs, including a Nuclear Energy Diploma program. He is also actively involved in research groups on nuclear physics, atomic and molecular physics, and nuclear technologies, and has collaborated internationally on theoretical materials science and energy policy. Dr. Galeano is a prolific author of scientific articles, technical reports, and policy analyses on nuclear energy, electricity markets, and energy transition in Latin America. His publications include peer-reviewed journal papers, book chapters, and outreach works aimed at improving public understanding of nuclear science. His contributions emphasize the role of nuclear technology in climate mitigation, energy security, and sustainable development. Beyond academia and industry, he plays a leadership role in professional organizations, serving in engineering societies and nuclear advocacy initiatives that promote the responsible adoption of nuclear technologies in Colombia and the region. His work bridges technical research, institutional capacity building, and public engagement. As Chief Editor, Dr. Galeano is committed to fostering a high-quality, globally inclusive platform for multidisciplinary research that advances nuclear science and technology across power generation, medicine, industry, agriculture, and environmental protection.
Editor-in-Chief, Biomedical Engineering · 2026–present
EIA University
Dr. Martha Elena Londoño, a distinguished researcher in Biomedical Engineering at EIA University with a Ph.D. in Engineering, has made significant contributions across 25 publications. Her research primarily focuses on healthcare innovations, particularly developing nanomaterials and advancing biomedical materials to tissue replacement. Key highlights of her work include developing and characterizing an injectable bone substitute combining PVA/Borax/CaCO3 with Demineralized Bone Matrix and creating nanomaterials like nanoparticles like nanorods from Colombian biodiversity and carbon dots from sources like spruce trees and African oil palm for ecotoxicity evaluation. Dr. Londoño's expertise also encompasses studying the bioactivity and degradation of bone substitute materials and the characterization of complex biomedical matrices. Her work in fluid dynamics within biological systems further showcases her diverse research interests in biomedical engineering. Her contributions are instrumental in advancing diagnostic and material technologies in healthcare, underlining her role as a leading figure in biomedical research and innovation.
ScienceBank está gobernada por sus miembros: únete a la Sociedad o escríbenos con tus preguntas.